β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma - Wikidata - wikimedia - TriplyDB

β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma

β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma

http://www.wikidata.org/entity/Q35012043

about

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets The positive clinical therapeutically effects of Escin on advanced thyroid cancer.Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability.Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.

P2860

Q26751224-E4B191FF-BFF6-473C-B746-199A87EFB0A7 Q33679565-2352D554-DEE9-4444-9EFF-7F6160A00DBA Q38713151-74B343B1-4301-4252-8722-278FC2C2BB94 Q38720813-4B3CE4E1-BDE6-4822-B492-E89EC0027A6F Q42183898-B04AF558-4AE6-4C99-AC2E-86B1F2C64588 Q46288383-780C8F81-B393-4648-B37A-7F801FEE6E79 Q48146413-D4C8A6EE-B3BA-4D45-AF54-9C4AF39F5458

P2860

β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma

http://www.wikidata.org/entity/Q35012043

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@ast

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@en

type

label

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@ast

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@en

prefLabel

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@ast

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@en

P1433

Q35012043-BF24BC6E-90E5-4A00-810E-0A15DB79ADFD

P1476

Q35012043-A7B9631F-4CFF-47FA-9B64-87DFF7732287

P2093

Q35012043-060ED874-FC1A-44E7-9139-9902A19CA637

Q35012043-42B8148B-5C0B-46CA-9E35-F9D3DC74B0D2

Q35012043-9B6B61F5-1F67-4F6E-AB7F-2738AD28F386

Q35012043-A1AD4A4E-E0A8-4DA4-B1E3-450E25F6AD3D

Q35012043-E25AC6F7-49BB-4425-BAF8-5A3886BF91AC

Q35012043-FCF25455-17A6-4CA7-A3EC-32714D92E719

P2860

Q35012043-08FAC775-EC37-4EFA-8627-C8CB1312A124

Q35012043-1168F6BA-1834-48AF-9BD0-8299125981EC

Q35012043-1175526A-F740-486C-BEA1-77F802886A7C

Q35012043-1256FD94-9DBA-49C8-B1C6-71FD2FDDF7EA

Q35012043-3813A33A-DA16-47B1-AD93-85E45100516C

Q35012043-3A6D365E-99D6-4181-B1B5-D061DB0AFE76

Q35012043-4A028691-FEDD-4090-974B-E18BF8EA46BF

Q35012043-4FDBE07C-2EA6-4C4F-A50F-541D7DD7F5BB

Q35012043-55A2E60B-5DA5-489B-8BBD-DA6E626CE1BD

Q35012043-5A46B7CC-2A9F-4CA3-9205-541C5B775D29

P304

Q35012043-7CFCAF80-31D3-4045-B5E6-349D26226281

P31

Q35012043-EA96AF15-CB47-4518-8786-174FF33AD519

P356

Q35012043-0F549D7E-11CA-4B58-BE1D-1843F3F7AF47

P407

Q35012043-B70F7883-0D45-4315-85CA-178136D6C515

P433

Q35012043-094D1FC6-768E-41EB-B737-DB8CB2CA75DA

P478

Q35012043-DFEBA67F-C61B-436C-96D6-D9250F48A772

P577

Q35012043-276C7BB7-57B6-4655-80EE-0ABD3391561D

P698

Q35012043-9D3EBD82-3BA5-42E0-9061-16155001A32A

P921

Q35012043-3C14BE9B-2A87-44B2-BCC2-CBFC002EC5CB

Q35012043-AA6E8BCD-6598-4665-AA87-C8D2DEA39232

P932

Q35012043-818FC126-769F-4A56-A90C-811B82DAD9E5

P356

WJG.V21.I4.1148

P1433

World Journal of Gastroenterology

P1476

β-escin reverses multidrug res ...... pathway in cholangiocarcinoma

@en

P2093

Cheng-Fu Cai

http://www.w3.org/2001/XMLSchema#string

Dong-Yan Shen

http://www.w3.org/2001/XMLSchema#string

Gui-Li Huang

http://www.w3.org/2001/XMLSchema#string

Hong-Yue Ren

http://www.w3.org/2001/XMLSchema#string

Qing-Xi Chen

http://www.w3.org/2001/XMLSchema#string

Qiu-Yan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

Wnt/beta-catenin signaling: components, mechanisms, and diseases

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Wnt/beta-catenin signaling in development and disease

Reversal of multidrug resitance by natural substances from plants

Wnt signalling in stem cells and cancer

Role of Wnt/β-catenin signaling in liver metabolism and cancer

Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation.

Aescin: pharmacology, pharmacokinetics and therapeutic profile.

An updated overview on Wnt signaling pathways: a prelude for more.

P304

1148-1157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I4.1148

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25632187

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

multiple drug resistance

P932

4306158

http://www.w3.org/2001/XMLSchema#string